Cholangiocarcinoma 2026: status quo, unmet needs and priorities
2025 · Nature Reviews Gastroenterology & Hepatology · 11 citations
https://doi.org/10.1038/s41575-025-01153-w
A
Alexander Link
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
38
Citations
4
h-index
1
i10-index
Alexander Link is an academic researcher from Marche Polytechnic University. The author has contributed to research in topics: Peptidase Inhibition and Analysis & Cancer Immunotherapy and Biomarkers & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 4, co-authored 13 publications.
ORCID: 0009-0004-0545-3161Papers by this author
worksSingle-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers
2025 · Journal of Experimental & Clinical Cancer Research · 4 citations
https://doi.org/10.1186/s13046-025-03567-5
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4–1BB: A preclinical study in multiple myeloma
2024 · Biomedicine & Pharmacotherapy · 3 citations
https://doi.org/10.1016/j.biopha.2024.116877
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat